Search

The COVID-19 pandemic confronts the world with urgent and unsolved challenges. The pandemic marks the third deadly outbreak due to a coronavirus after severe acute respiratory syndrome in 2003 and Middle East respiratory syndrome in 2012.1, 2 In the absence of effective testing and contact tracing...

The Lancet COVID-19 Commissioners, Task Force Chairs, and Commission Secretariat Executive summary The Lancet COVID-19 Commission was launched on July 9, 2020, to assist governments, civil society, and UN institutions in responding effectively to the COVID-19 pandemic. The Commission aims to offer...

WHO and partners have learnt from the mis-steps in the response to the 2009 H1N1 influenza pandemic1 and established the Access to COVID-19 Tools (ACT) Accelerator to promote equitable access to vaccines, therapeutics, and diagnostics.2 However, many high-income countries already have bilateral...

The Lancet COVID-19 Commission calls for three urgent actions in the COVID-19 response (our broader overview is available on our website). First, all regions with high rates of new COVID-19 cases, including the USA and the European Union (EU), should intensify measures to minimise community...

Here we provide a brief “primer” to assist healthcare providers in correcting a growing body of misinformation surrounding COVID-19 vaccines. To date, just over 100 million COVID-19 immunizations have been administered, led by the United States accounting for more than one-third (35 million)...

The Lancet COVID-19 Commission Task Force for Public Health Measures to Suppress the Pandemic was launched to identify critical points for consideration by governments on public health interventions to control coronavirus disease 2019 (COVID-19). Drawing on our review of published studies of data...

Summary Several global efforts are underway to develop COVID-19 vaccines, and interim analyses from phase 3 clinical testing have been announced by nine organisations: Pfizer, the Gamaleya Research Institute of Epidemiology and Microbiology, Moderna, AstraZeneca, Sinopharm Group, Sinovac Biotech...